Eric D Bateman
Overview
Explore the profile of Eric D Bateman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
159
Citations
9345
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Huang K, Liu M, Wang W, Shi H, Shi C, Wang Y, et al.
Allergy
. 2025 Mar;
PMID: 40059338
No abstract available.
2.
Shekar S, Bachmann M, Bateman E, Stelmach R, Cruz A, Zonta R, et al.
BMJ Glob Health
. 2024 Oct;
9(Suppl 3).
PMID: 39467591
Background: Training primary care doctors and nurses to use Practical Approach to Care Kit (PACK) improved management of asthma and chronic obstructive pulmonary disease (COPD) in a previous randomised trial....
3.
Hoof I, Bonnelykke K, Stranzl T, Brand S, Li X, Shamji M, et al.
Thorax
. 2023 Dec;
79(4):332-339.
PMID: 38160049
Background: Hypersensitivity to house dust mite (HDM) allergens is a common cause of allergic asthma symptoms and can be effectively treated with allergy immunotherapy (AIT). Objective: To investigate whether genetic...
4.
Levy M, Bateman E, Allan K, Bacharier L, Bonini M, Boulet L, et al.
Lancet
. 2023 Jul;
402(10406):1012-1016.
PMID: 37480934
No abstract available.
5.
Rabe K, FitzGerald J, Bateman E, Castro M, Pavord I, Maspero J, et al.
J Allergy Clin Immunol Pract
. 2022 Aug;
10(11):2916-2924.e4.
PMID: 36028446
Background: The Global Initiative for Asthma report recommends consideration of add-on biologics for patients with type 2 inflammation (blood eosinophils ≥150 cells/μL, fractional exhaled nitric oxide [Feno] ≥20 parts per...
6.
Reddel H, Bacharier L, Bateman E, Brightling C, Brusselle G, Buhl R, et al.
Arch Bronconeumol
. 2022 Mar;
58(1):35-51.
PMID: 35245179
The Global Initiative for Asthma (GINA) Strategy Report provides clinicians with an annually updated evidence-based strategy for asthma management and prevention, which can be adapted for local circumstances (e.g., medication...
7.
Bateman E, Price D, Wang H, Schonffeldt P, Catanzariti A, van der Valk R, et al.
Eur Respir J
. 2022 Feb;
59(6).
PMID: 35210324
No abstract available.
8.
Mortimer K, Reddel H, Pitrez P, Bateman E
Eur Respir J
. 2022 Feb;
60(3).
PMID: 35210321
Asthma is the most common noncommunicable disease in children, and among the most common in adults. The great majority of people with asthma live in low and middle income countries...
9.
Bateman E, Khan A, Xu Y, Guyot P, Chao J, Kamat S, et al.
Respir Med
. 2022 Jan;
191:106088.
PMID: 35090691
No abstract available.
10.
Bateman E, Khan A, Xu Y, Guyot P, Chao J, Kamat S, et al.
Respir Med
. 2022 Jan;
191:105991.
PMID: 35090688
Background: Currently, five biologic treatment options are available for use in patients with uncontrolled persistent asthma: three interleukin (IL)-5 antagonists, which either bind to the anti-IL-5 ligand (mepolizumab, reslizumab) or...